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Introduction
The tumor suppressor BRCA2 is a key protein orchestrating 
DNA repair by homologous recombination (HR; Heyer et al., 
2010). As such, BRCA2 interacts with numerous other proteins, 
including RAD51 and PALB2, as well as with single-stranded 
(ss) and double-stranded (ds) DNA (Siaud et al., 2011). BRCA2 
plays an important role in replacing RAD51 in exchange for RPA 
on ssDNA, promoting the key RAD51-mediated strand exchange 
reaction of HR (Jensen et al., 2010; Liu et al., 2010; Thorslund 
et al., 2010). Like other HR repair proteins, BRCA2 accumulates 
into high local concentrations commonly called damage-induced 
foci in response to DNA damage. The mechanisms promoting 
this high local concentration and accumulation are not well de-
fined but likely involve transient and more stable binding to im-
mobile elements in the nucleus.
To define how proteins such as BRCA2 arrive at the needed 
nuclear location at the right time, we set out to follow in vivo 
diffusive behavior directly using a combination of methods. The 
mobility of individual components in live cells can be investi-
gated by fluorescence correlation spectroscopy (FCS; Haustein 
and Schwille, 2007) and single-particle tracking (SPT; Jaqaman 
et al., 2008; Chenouard et al., 2014). FCS depends strongly on 
mathematical models and their interpretation to derive values 
for diffusive behavior. SPT monitors the trajectories of true single 
particles, directly revealing their heterogeneous behavior with 
transitions and binding events. Observing individual molecu-
lar entities by SPT in living mammalian cells requires methods 
such as total internal reflection fluorescence (TIRF) or oblique 
laser illumination microscopy (Tokunaga et al., 2008) that ef-
fectively reduce background fluorescence. TIRF is effectively 
applied to describe diffusion of membrane proteins, but because 
the nucleus is largely inaccessible by this method there are only 
Genome maintenance by homologous recombi-nation depends on coordinating many proteins in time and space to assemble at DNA break sites. 
To understand this process, we followed the mobility of 
BRCA2, a critical recombination mediator, in live cells at 
the single-molecule level using both single-particle track-
ing and fluorescence correlation spectroscopy. BRCA2-
GFP and -YFP were compared to distinguish diffusion 
from fluorophore behavior. Diffusive behavior of fluor-
escent RAD51 and RAD54 was determined for comparison. 
All fluorescent proteins were expressed from endogenous 
loci. We found that nuclear BRCA2 existed in oligomeric 
clusters, and exhibited heterogeneous mobility. DNA dam-
age increased BRCA2 transient binding, presumably in-
cluding binding to damaged sites. Despite its very different 
size, RAD51 displayed mobility similar to BRCA2, which 
indicates physical interaction between these proteins both 
before and after induction of DNA damage. We propose 
that BRCA2-mediated sequestration of nuclear RAD51 
serves to prevent inappropriate DNA interactions and that 
all RAD51 is delivered to DNA damage sites in associa-
tion with BRCA2.
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GFP-tagged BRCA2 particles in live mouse ES cells and char-
acterize their heterogeneous mobile behavior.
BRCA2 assures that RAD51 is in the right place in sev-
eral distinct ways; BRCA2 is involved in nuclear localization 
of RAD51 (Davies et al., 2001; Jeyasekharan et al., 2013), 
BRCA2 is needed for concentration of RAD51 in foci at sites of 
DNA damage (Chen et al., 1999), BRCA2 specifically delivers 
RAD51 to replace RPA on DNA breaks (Jensen et al., 2010; 
Liu et al., 2010; Thorslund et al., 2010), and BRCA2 is involved 
with RAD51 in stabilizing stalled replication forks (Schlacher 
et al., 2011). Therefore, it is essential to know how these pro-
teins move about the nucleus, how their movement is affected 
by DNA damage induction, and to what extent their behavior 
is coordinated. Including fluorescent tags with distinct photo-
physical properties and applying multiple quantitative imaging 
methods compared with simulations provided a consistent de-
scription of BRCA2 diffusive behavior and revealed new details. 
Both single-molecule bleaching step analysis (Kerssemakers 
et al., 2006; Ulbrich and Isacoff, 2007) and FCS indicated that 
BRCA2 moves about the nucleus as multimeric clusters. SPT 
revealed remarkable heterogeneity in the behavior of BRCA2, 
including transient binding on the time scale of several hundreds 
of milliseconds, which was confirmed by FCS and simulations. 
DNA damage induction caused both an increase in the num-
ber of bound BRCA2 and in the time bound. RAD51 moved 
in the nucleus just like BRCA2, indicating that the two pro-
teins travel in the same complex. Indeed, the detected RAD51 
was either immobile or diffusing with the same properties as 
BRCA2, which indicates that there is little or no free RAD51 in 
the nucleus of these cells. We discuss the implications of this 
observation for RAD51 assembly onto DNA for HR repair. The 
sensitivity of this approach and the ability to generate protein 
variants expressed from endogenous loci will enable dissecting 
the events driving DNA damage–induced foci formation and 
required for DNA repair (Agarwal et al., 2011).
Results
Fluorescent fusion of endogenous BRCA2 
for live cell imaging
We used gene targeting with a promoterless cassette to produce 
Brca2GFP/GFP mouse ES cell lines such that EGFP is added to 
the end of the Brca2 coding sequence (Fig. S1, A and B), per-
formed Southern and Western blotting (Fig. S1, C and D), and 
compared them to parental cells in a series of functional assays 
(Fig. S1, E–H). Brca2GPF/GFP cells were not impaired in HR ef-
ficiency as measured by the gene-targeting assay at the Rad54 
locus (Abraham et al., 2003; mean targeting efficiency ± SEM: 
46.5 ± 6.0% and 25.1 ± 4.5% for Brca2GPF/GFP and Brca2WT/WT 
cells, respectively). Additionally, Brca2GPF/GFP cells were simi-
lar to Brca2WT/WT in the sensitivity to ionizing radiation (IR), cis-
platin, and a PARP inhibitor PJ-34 (Fig. S1 E). FACS analysis 
of the Brca2GFP/GFP cells revealed increasing levels of BRCA2-
GFP through S-phase peaking in G2/M (Fig. S1 F), matching 
the tight cell cycle dependence of the BRCA2 expression described 
previously (Vaughn et al., 1996). Mass-spectrometric analysis 
of the proteins coprecipitated with BRCA2-GFP identified 
a few reports of nuclear components analyzed by SPT (Grünwald 
et al., 2008; Mazza et al., 2012; Van Royen et al., 2014). We 
applied SPT to determine the functional behavior of nuclear 
BRCA2. This allowed us to separately determine the frequency 
at which proteins become immobile and the duration of immo-
bilization for individual proteins, which could both contribute 
to accumulation in DNA damage–induced nuclear foci.
Because endogenous expression levels are essential to 
maintain function based on concentration-dependent inter-
actions, we created BRCA2-GFP knock-in embryonic stem (ES) 
cell lines for in vivo SPT. GFP-tagged RAD51 and RAD54 
were also expressed from endogenous loci in the work de-
scribed here. Endogenous expression is particularly important 
for RAD51 and BRCA2, whose expression levels appear to be 
coordinated in vivo (Magwood et al., 2013). The endogenous 
BRCA2 concentration is sufficiently low such that individual 
fluorescent BRCA2 particles can be detected as diffraction-
limited spots without additional photo-physical manipulation. 
Using oblique laser illumination (Tokunaga et al., 2008) in com-
bination with SPT (Jaqaman et al., 2008), we could follow single 
Figure 1. Single-molecule detections in live cells can be clearly identified. 
(A) Oblique laser illumination fluorescence images of the wild-type ES cells 
(Brca2WT/WT) and the heterozygous and homozygous Brca2-GFP knock-in 
cells. The nuclei of Brca2-GFP knock-in cells contain low-fluorescent diffusing 
and highly fluorescent bound particles. Brca2WT/WT cell nuclei lack a dis-
tinct fluorescence signal. Cell nuclei were manually demarcated based on 
bright-field and fluorescence images and are indicated by white lines. Bar, 
5 µm. (B) Each detected pixel area above background was fitted with a 2D 
Gaussian PSF characterized by a sigma and an intensity value, here based 
on 8-bit images. The intensity-sigma data pairs were plotted for all detec-
tions from one image stack. The data shown are representative of multiple 
experimental repeats (the number of individual stacks is >200). Camera 
noise contributes false detections (blue crosses), also found in Brca2WT/WT 
cell nuclei and outside cell nuclei, which lie below an approximated expo-
nential curve derived from this raw data (see Fig. S3 A). Remaining true 
detections are displayed as red circles. One pixel is 70 nm.
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GFP-tagged protein (Fig. 1 B and Fig. S3 A). Given our image 
acquisition and particle tracking parameters, the largest pos-
sible diffusion constant D of the tracked BRCA2-GFP particles 
would theoretically be 3.0 µm2/s. Faster-diffusing species would 
not produce diffraction-limited spots. This routine allowed sen-
sitive detection and quantitative characterization of (transient) 
binding (Fig. 2, A and B).
Defining mobile and bound behavior  
of BRCA2
Individual tracked particles were classified as mobile or immo-
bile based on a cutoff value of 200 nm for total displacement. 
Hereafter, we refer to immobile BRCA2 particles as bound. The 
bound track type likely represented interactions of BRCA2 
with relatively stationary nuclear objects, such as chromosomes 
and chromatin-associated components. For mobile BRCA2-GFP 
with high confidence most known BRCA2 interaction part-
ners, including RAD51, PALB2, and MORF4L1 (Table S1). 
BRCA2-GFP formed IR-induced foci, which colocalized with 
Trp53BP1 (Fig. S1, G and H). IR-induced RAD51 foci formation 
in the Brca2GFP/GFP cells was also normal (Fig. S2). We conclude 
that the BRCA2-GFP fusion produced was active in HR repair.
Detecting and tracking individual 
fluorescent particles in living cells
Using oblique laser illumination, mobile particles with diffraction- 
limited fluorescence signal (250 nm full width at half maxi-
mum) were detected in the Brca2GFP/GFP and Brca2GFP/WT cell 
lines; no such unambiguous detections were made in Brca2WT/WT  
cells (Fig. 1 A and Video 1). We developed a method for re-
moving false detections, such as those found in cell-free areas 
or Brca2WT/WT cell nuclei, to distil signals that arise indeed from 
Figure 2. BRCA2 displays heterogeneous mobility. (A) An 
image sequence showing diffusion of two BRCA2 particles, 
coming from an area above or below the observed focal 
plane, with transient binding. Individual frames are sepa-
rated by 50 ms. (B) Tracked BRCA2 particle trajectories 
from the sequence in A are displayed as yellow lines su-
perimposed on the 14th frame. (C) Other BRCA2 tracks 
representative of mobile or bound species. Bars, 0.5 µm. 
(D and F) The histograms show all particle jumps r from 
tracks classified as either bound (D) or mobile (F), respec-
tively. (E and G) From these histograms, CDFs, normalized 
between 1 and 0 and displayed as decay, were derived 
and subjected to fitting with three components. The blue 
and red lines represent raw and fitted data, respectively. 
The data shown, obtained under nondamaged condi-
tions, are representative of multiple experimental repeats 
(n > 10). Each dataset is based on at least 20 cells.
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B = 40 ms and F = 30 ms for the bound and freely mobile states, re-
spectively (Fig. S4). A slower diffusion constant of D = 0.4 µm2/s 
without any binding events (B = 0 ms) in the simulations pro-
duced particle jump histograms that deviated significantly from 
the measured data (Fig. S4). Thus, transient interactions on the 
order of 20–40 ms had to be included to match the simulations 
with our data, indicating that nuclear BRCA2 is frequently im-
mobile. This has important implications for the interpretation of 
FCS data presented in the following section.
The behavior of BRCA2 in living cells has been described 
using FCS (Jeyasekharan et al., 2010). To directly compare re-
sults from this method with SPT, we performed FCS on our cell 
lines. To discriminate protein diffusion and binding events from 
the photo-physical behavior of the fluorescent proteins, we first 
performed FCS on free nuclear GFP or YFP expressed at low 
levels in ES cells (Fig. 3). The identical size but different blink-
ing rates of GFP and YFP were used to eliminate the possible 
confounding influence of blinking in FCS analysis. For GFP, 
blinking and diffusion rates are so similar that their time decay 
component cannot be resolved, resulting in a single component 
of 330 µs (reflecting both processes), correlating with a pseudo-
diffusion constant of 33.3 µm2/s also found by others (Haupts 
et al., 1998). Because of its different blinking behavior, YFP 
displays two main autocorrelation function (ACF) decay com-
ponents, one at 87 µs (50%), which is characteristic of blinking, 
and the other at 641 µs (46.5%), which is characteristic of diffu-
sion for a protein of this size (within the accuracy allowed by 
this method, not separable from the 330 µs resulting from the 
mixed diffusion/blinking components of GFP). Hence, any GFP-
tagged protein will give a decay component for blinking that 
makes FCS measurements of diffusion in the range of 300–
650 µs ambiguous.
For comparison in FCS, we engineered Brca2YFP/YFP cells, 
which, except for the fluorophore, are identical to the Brca2GFP/GFP 
cells (Fig. S1 E). For FCS analysis of these Brca2YFP/YFP and 
Brca2GFP/GFP cells, we fixed the ACF component due to blink-
ing of G/YFP to the values measured earlier and at 50 ± 5%. 
The remaining free mobility components were fitted to decay con-
stants of 27.3 ms (49%) for BRCA2-GFP and to 5.4 ms (43%) 
for BRCA2-YFP, corresponding to Dapp of 0.45 and 2.0 µm2/s, 
respectively. We attribute the obvious discrepancy to different 
fluorophore properties, such as differences in bleaching and chro-
mophore maturation rates (Schwille et al., 2000; Nagai et al., 
2002). Importantly, neither BRCA2 fusion included fast-diffusing 
species, with decay constants in the range of 300–650 µs (corre-
sponding to 15.4–33.3 µm2/s), even when we force fitted the ACF 
curves in this range. The FCS data are in good agreement with 
other published data (Jeyasekharan et al., 2010) on a BRCA2-GFP 
fusion protein in chicken DT40 cells. However, by comparing 
particles, 3D diffusion limits observation to a few frames unless 
the particles also had transient interactions (Fig. 2, A–C). To 
determine apparent diffusion constants Dapp from the combined 
BRCA2 tracking data, we assume that the mean behavior of 
multiple particles observed over a brief period is representative 
of longtime observation of a single particle (He et al., 2008). 
The particle jump distribution for immobile and mobile track 
type (Fig. 2, D and F, respectively) was analyzed by fitting the 
cumulative distribution function (CDF) to yield a Dapp of Di with 
amplitude Ai summarized in Table 1. The apparent “mobility” 
components below Di = 0.1 µm2/s indicate a bound state where 
BRCA2 is presumably bound to nuclear structures that retain 
some mobility due to restricted Brownian motion. The third and 
smallest component D3 = 0.002 µm2/s stems from camera noise 
and mechanical fluctuations, as these values were also detected 
for fluorescent beads immobilized on coverslips (Fig. S3 B and 
Table S2). The mobility component D1 = 0.84 µm2/s (5% of 
particle jumps for immobile tracks) was due to bound BRCA2-
GFP particles that become mobile (for one or two steps) dur-
ing the observation period, or vice versa. The mobile BRCA2 
particles had a Dapp of D1 = 1.44 µm2/s. Even mobile particles 
were transiently bound for 50% of the time. The percentage 
of different mobility components is a read-out for the extent of 
transient BRCA2 interactions in nuclei.
BRCA2 behavior was also analyzed in a different cell 
type to test generality. We engineered HeLa cell lines stably ex-
pressing full-length human BRCA2 fused with EGFP at either 
the N or C terminus, along with the endogenous BRCA2 pro-
tein. Despite the numerous differences in the origin of the cells 
(human vs. mouse, transformed vs. ES), mode of expression 
(ectopic vs. knock-in), and the presence of the untagged pro-
tein, qualitatively, GFP-BRCA2 and BRCA2-GFP proteins in 
HeLa cells displayed the same diffusive behavior as observed in 
ES cells (Videos 2 and 3). This indicates that the general prop-
erties of BRCA2 fusion protein mobility in vivo are not associ-
ated solely with ES cells.
Frequent transient binding by BRCA2 
confirmed by simulations and FCS
3D particle movement is projected into 2D for SPT, both limit-
ing the time a particle can be followed and affecting the moni-
tored tracked segments (van den Wildenberg et al., 2011). To 
disentangle these effects, we performed simulations in 3D with 
synthetic data, convolved with a point spread function (PSF) 
matching the microscope used, generated using (variable) dif-
fusion values similar to those obtained experimentally. We ob-
tained theoretical particle jump histograms that matched our 
data for mobile tracks using D = 2 µm2/s only when we included 
transient binding events characterized by time constants of 
Table 1. Summary of the CDF diffusion analysis results for tracked BRCA2-GFP particles in live, untreated Brca2GFP/GFP cells
Type D1 A1 D2 A2 D3 A3 
µm2/s % µm2/s % µm2/s % µm
1 (bound) 0.84 5.4 0.032 36.1 0.002 58.5 0.008
2 (mobile) 1.44 50.0 0.064 33.9 0.002 16.1 0.011
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particles could be tracked as displayed in the 2D histogram of 
protein mobility (Fig. 4 A). These 2D histograms represent the 
relative proportion of time that the tracked particles spent in the 
mobile and bound state. Based on molecular weight, RAD51 
is much smaller than BRCA2 and could display fast diffusion. 
However, we observed RAD51 behavior similar to BRCA2, 
with transient binding and an overall low mobility (Fig. 4 A).
This suggests that diffusive RAD51 is associated with 
BRCA2, a known interacting partner (Sharan et al., 1997). To 
determine if RAD51 diffusive behavior was due to interaction 
with BRCA2, we disrupted their interaction. Expression of the 
BRC3 peptide, which binds RAD51 and disrupts BRCA2 inter-
action (Chen et al., 1999), caused increased mobility of nuclear 
RAD51-GFP, and slow or transiently bound particles were no 
longer observed (Fig. 4 B and Video 6). Increased RAD51-GFP 
mobility was quantified by determining the number of particles 
that could be detected with our routine (Fig. 1 B and Fig. S3 A) 
in individual cells (Fig. 4 C). Transfected cells were distinguished 
from untransfected cells by expression of RFP from a cotrans-
fected plasmid. RAD51-GFP particles, with mobility similar to 
BRCA2, detected by this routine (Fig. 4, C and D) were abundant 
in most RFP-negative nuclei. In contrast, RAD51 detections are 
almost entirely lost in RFP-positive nuclei expressing the BRC3 
peptide but not in RFP-positive nuclei expressing the BRC3-FK 
peptide, which is unable to disrupt the BRCA2–RAD51 inter-
action (Chen et al., 1999; Davies et al., 2001). Note that only cells 
exposed to the BRC3-expressing plasmid show <500 detections 
(Fig. 4 D), including some of the RFP-negative cells that have 
probably been successfully transfected but did not express the 
RFP plasmid well enough for detection. BRCA2 diffusive behav-
ior was not affected by BRC3 expression. The similarity of 
RAD51 and BRCA2 mobility was caused by their association, as 
disrupting this interaction increased RAD51 mobility.
YFP, GFP, and respective fusion proteins directly, we note that 
detection of apparent fast diffusing BRCA2 could be caused 
by GFP blinking. An increase in this component (Jeyasekharan 
et al., 2010) could be explained by GFP-tagged proteins being 
more frequently immobile in the detection volume. It is also 
possible that BRCA2 behaves differently in DT40 cells compared 
with mouse ES cells. We did not detect fast-diffusing BRCA2 
species in the BRCA2-YFP cell line, where the timing of this pro-
cess is well separated from fluorescent protein blinking, and con-
clude that only slowly diffusing BRCA2 particles (D < 2 µm2/s) 
are present in our ES cells. Because transient binding was observed 
in our SPT data and was needed to produce accurate simulations, 
we interpret the ACF time component of 27.3 ms (0.45 µm2/s) as 
including transient binding rather than diffusion only.
BRCA2 and RAD51 display similar 
diffusion behavior
We compared the behavior of BRCA2 with two additional HR 
proteins. Both Rad51GFP/WT and Rad54GFP/ ES cells were simi-
larly analyzed by SPT (Videos 1, 4, and 5). Although tagged 
versions of RAD51 do not maintain full function, this RAD51-
GFP fusion interacts with BRCA2 and compensates for loss 
of RAD51 in cell survival (Yu et al., 2003). The Rad54GFP/ 
cells display normal DNA damage sensitivity and HR func-
tions (Agarwal et al., 2011). Both RAD51 and RAD54 dif-
fer from BRCA2 significantly in molecular weight, and thus 
we expected diffusion of monomeric forms. RAD51, but not 
RAD54, can interact directly with BRCA2. As expected from 
known nuclear behavior (Agarwal et al., 2011), RAD54 dis-
played local accumulations in spontaneous foci in a background 
of uniform nuclear fluorescence, caused by fast diffusing pro-
tein. Individual RAD54-GFP particles with diffusion behavior 
similar to BRCA2 were not observed. Only immobile RAD54 
Figure 3. Mobility of BRCA2 fusion proteins de-
termined by FCS. (A) Autocorrelation curves C() 
were fitted with a three-component model, for ES 
cells with homozygous BRCA2-GFP and BRCA2-
YFP knock-ins and for ES cells transiently expres-
sing GFP and YFP, as indicated by color. Raw 
and fitted data are shown as solid and broken 
lines, respectively. ACF curves were postnormal-
ized between 1 and 2 for better comparison of 
the diffusion characteristics, but the residuals were 
left unchanged. (B) The intensity fluctuation raw 
data and the photon counting histograms are dis-
played for cells transiently expressing GFP at a 
low concentration and Brca2-GFP homozygous 
knock-in cells, using an integration time of 4 ms. 
Although the photon counting histogram for GFP-
expressing cells is symmetric, the histogram for 
BRCA2-GFP is skewed, suggesting a hetero-
geneous BRCA2-GFP population consisting of 
BRCA2 oligomers with varying protein number. 
The data shown are representative of multiple 
experimental repeats (n = 10 cells).
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(Fig. S5 B). Even though the data were obtained from a hetero-
geneous cell population in which the respective plasmids may or 
may not be expressed, averaged FRAP curves (from 8–20 cells) 
show that expressing the BRC3 peptide results in faster RAD51 
recovery after photobleaching (Fig. S5 C). In addition, BRC3-
expressing cells showed a higher final level of RAD51-GFP 
fluorescence recovery. In the time window of 8–10 s final, re-
covery values for cells expressing BRC3, BRC3-FK, or no 
plasmid reached 0.904 ± 0.003, 0.860 ± 0.004, and 0.863 ± 
0.005 relative recovery (mean ± 2 × SEM), respectively. These 
FRAP data support the conclusion that mobile RAD51 is travel-
ing in complex with BRCA2 in the nucleus.
As further evidence for the co-mobility of BRCA2–
RAD51, we disrupted this interaction in an independent 
manner. Applying (mild) hyperthermia will degrade BRCA2 but 
not RAD51 (Krawczyk et al., 2011). We analyzed protein diffu-
sion by SPT in Rad51GFP/WT cells before and after hyperthermia 
treatment. Although BRCA2 degradation is not complete in these 
conditions, we observed a reduction in the number (mean ± 2 × 
SEM) of detectable RAD51-GFP particles per nucleus from 
The diffusive behavior of BRCA2 and RAD51 was also 
analyzed by FRAP. We were able to obtain FRAP data even 
though BRCA2 is expressed at a low level and was therefore 
technically very challenging to follow in this way, as also noted 
by others (Jeyasekharan et al., 2010). The fluorescence recovery 
behavior of RAD51-GFP was in fact even slower than BRCA2-
GFP, which indicates the lack of a faster freely diffusing pool of 
RAD51 and likely reflects a pool of immobile protein (Fig. S5 A). 
This assay confirms that BRCA2 and RAD51, two very differently 
sized proteins, both diffuse relatively slowly in the nucleus. We 
also performed FRAP analysis on the Rad51GFP/WT cell line after 
transfection to express the BRC3 peptide, which disrupts inter-
action with BRCA2, as explained in the previous section. Although 
the RFP marker protein could not be used in this case, we did detect 
two populations of cells after transfection based on appearance 
of spontaneous RAD51-GFP foci (Fig. S5 B). About half of the cells 
transfected with the BRC3 construct had nuclei with uniform 
fluorescence lacking foci, whereas all nuclei of cells from con-
trol transfections, either with the control peptide (BRC3-FK) 
or Lipofectamine alone, had spontaneous RAD51-GFP foci 
Figure 4. BRCA2 and RAD51 display similar diffusive behavior in live cells that is disrupted by BRC3 overexpression. (A, top) Oblique illumination images 
of live cells expressing BRCA2-GFP, RAD51-GFP, and RAD54-GFP. Slowly diffusing particles were detected for both BRCA2 and RAD51. RAD54 was de-
tected only as immobile clusters. Bars, 5 µm. (A, bottom) 2D histograms for all three proteins display the distribution of residence times in the mobile (particle 
jumps > 200 nm) and bound state (particle jumps < 200 nm) of all detected tracks. The insets illustrate representative tracks for characteristic different mobil-
ity behaviors and are also shown in Fig. 2 (B and C). The relative frequencies for tracks with the indicated times spent in the bound and mobile state are 
represented by the colors defined on the right. The number of acquired tracks was 4126 for BRCA2-GFP, 791 for RAD51-GFP, and 250 for RAD54-GFP, 
from at least four fields and 16 nuclei per sample. (B) Fluorescence images of cells transfected with BRC3 peptide expression vector and/or an RFP expre-
ssion vector. Upon expression of BRC3-FK peptide, which is deficient for RAD51 binding, slowly diffusing and transiently binding RAD51-GFP particles 
(green color channel) can be detected in Rad51GFP/WT cell nuclei. Upon BRC3 peptide expression, nuclei of most transfected cells now show bright, uniform 
RAD51-GFP fluorescence, indicating that BRCA2–RAD51 interactions are disrupted and RAD51 mobility is enhanced. BRC3 expression did not alter the 
mobile behavior of BRCA2-GFP. Bars, 5 µm. (C) Quantification of true detections (red circles) as in Fig. 1 B, in RFP-positive and -negative cells expressing 
BRC3, BRC3-FK, or control transfection. Because of the relatively high RAD51 concentration (compared with BRCA2-GFP), and therefore enhanced 
fluorescence level, only relevant detections in the  range of 1–3 were analyzed. Additionally, the exponential function was set off by 5 AU because the 
RFP+ BRC3 dataset did not have any detections to use for deriving a cutoff curve. Example data representative of individual video stacks are displayed. 
(D) Number of detections per condition (5–7 nuclei, number of initial detections: 5,000–12,000). The error bar represents the mean with the 95% confidence 
interval. Thus, BRC3-expressing cells have significantly fewer RAD51 detections than cells subjected to control transfection or BRC3-FK expression.
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or a distribution between 1 and 10. Based on the conserva-
tive estimate, we obtain a mean value of 3.12 fluorophores per 
BRCA2-GFP particle. In contrast, applying the second method, 
the larger accumulations known as spontaneous foci were esti-
mated to include 20–100 BRCA2 molecules.
BRCA2 binding increases upon DNA 
damage induction
In response to certain DNA lesions, BRCA2 and other HR pro-
teins accumulate into foci (Haaf et al., 1995; Chen et al., 1998; 
Essers et al., 2002b). Although foci including tens to hundreds of 
proteins appear immobile, individual proteins exchange at varying 
rates (Tan et al., 1999; Essers et al., 2006; Agarwal et al., 2011). 
Both the mechanism of accumulation and differential exchange 
rates are not understood. To describe changes in the behavior of 
individual BRCA2 particles that contribute to focus formation, 
we challenged cells with well-characterized damaging agents 
and determined the effect on BRCA2 with respect to the mobility 
and transient binding parameters. The BRCA2-GFP–expressing 
cells were treated with three different damaging agents using 
established dosage and timing protocols (Essers et al., 2006). 
The initial lesions induced by IR, mitomycin C (MMC), and 
hydroxy-urea (HU) include DNA double-strand breaks (DSBs), 
interstrand cross-links, and stalled and collapsed replication forks, 
respectively. In all cases, the resulting DNA damage is repaired 
by HR and induces formation of BRCA2 foci. When following 
individual particles (distinct from focal accumulations) by SPT in 
living cells, the fraction of bound BRCA2 increased in response 
to all three damaging agents in a similar fashion (Fig. 6 A). In the 
case of IR, this was most pronounced after 2 h, whereas after 
5 h, when DNA repair is mostly complete ( van Veelen et al., 2005; 
Agarwal et al., 2011), BRCA2 behavior had reverted to that of 
undamaged cells. DNA damage inflicted by IR, MMC, and HU 
caused a 15%, 16%, and 12% increase in bound BRCA2-GFP 
1,022 ± 286 to 411 ± 156 for control conditions and hyper-
thermia, respectively (12 and 17 nuclei, normalized for nuclear 
cross section size). The remaining particles that can be tracked 
are likely due to residual BRCA2 in some cells after this hy-
perthermia treatment. As in the case of BRC3 peptide expres-
sion, the decrease of detectable RAD51-GFP entities indicates 
increased mobility.
BRCA2 diffuses as oligomeric clusters
The FCS and SPT results indicated that the mobile BRCA2 par-
ticles detected were often multimeric. We did not detect GFP 
blinking during SPT, which would be expected for single fluor-
ophores given the time scale of our observations (Dickson 
et al., 1997; Montenegro Gouveia et al., 2010). In addition, the 
diffusing diffraction-limited particles varied in fluorescence in-
tensity, even in the same regions of interest (ROIs) where inten-
sity variation due to oblique illumination would not be a factor. 
Fluorescence intensity variation was also evident in the photon 
count histograms from the raw FCS data (compare BRCA2-GFP 
to GFP in Fig. 3 B) that were clearly skewed toward higher fluor-
escence intensity values for BRCA2-GFP compared with GFP 
alone. We determined the number of fluorescent molecules in 
individual BRCA2 particles from fluorescence bleaching traces 
from fixed cells (Kerssemakers et al., 2006; Xie et al., 2008; 
Fig. 5 A). The intensity of a single fluorophore was defined as 
the mean step size (Fig. 5 B) extracted from the bleaching traces 
by fitting a step function (Kerssemakers et al., 2006; Fig. 5 A, 
red line). The number of fluorophores in the diffraction-limited 
BRCA2 particles was determined by two methods: (1) by count-
ing steps equal or larger than the mean step size or (2) by di-
viding the difference in initial and final intensity by the mean 
step size (Fig. 5, C and D). Both determinations indicated that 
most single-entity, diffraction-limited particles detected were 
multimeric, including equal portions of 1, 2, or 3 fluorophores 
Figure 5. BRCA2-GFP is oligomeric in cells.  
(A) Fluorescence intensity bleaching traces (blue 
line) from six fixed cells were acquired by inte-
grating the fluorescence intensity of 5 × 5-pixel 
windows centered around an intensity maximum 
and corrected for background using the mean 
value of the surrounding 9 × 9 frame (gray; 
see inset). (B) A histogram of the steps (n = 
360) obtained from the step-function fit (red 
line in A) was used to estimate the mean step 
size by fitting the distribution with a Gaussian 
function. This mean step size, as mean intensity 
per GFP, was used to determine the number of 
BRCA2-GFP molecules per fluorescent object in 
two different ways. (C) Steps larger or equal to 
this mean step size were counted; steps more 
than twice the size of this mean were calculated 
as two BRCA2-GFP molecules (n = 90 traces 
with at least one BRCA2-GFP). (D) Alternatively, 
the difference between initial and final intensity 
in the bleaching traces (n = 118 with at least 
one BRCA2-GFP) was divided by the mean step 
size to determine the number of molecules per 
BRCA2 cluster. The data shown are representa-
tive of multiple experimental repeats (n = 3).
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BRCA2 particles, the methods we applied are not ideally suited 
for analysis of foci, accumulations typically including tens to hun-
dreds of proteins. The detected BRCA2 clusters, mobile and im-
mobile, we analyzed contained <10 BRCA2 molecules.
Discussion
We have followed the native behavior of three core HR proteins 
in the nuclei of living mammalian cells by combining endog-
enous expression of fluorescent-tagged proteins with multiple 
complementary imaging and analysis methods. This revealed 
several previously uncharacterized aspects of nuclear BRCA2 
behavior. First, following individual complexes by SPT, we 
found that nuclear BRCA2 is characterized by frequent tran-
sient interactions. This behavior appears to be a fundamental 
property of BRCA2 observed and quantified under a variety of 
conditions in mouse ES cells and observed to be qualitatively 
similar in human cells. BRCA2 or another member of its com-
plex may frequently and transiently interact with genomic DNA, 
particles, respectively. The diffusion constants of mobile BRCA2 
did not change significantly in response to DNA damage (Table 2). 
The CDF curves obtained from all tracked particles displayed a 
clear downward shift after DNA damage that is indicative of re-
duced mobility (Fig. 6 B). This effect is quantitatively reflected 
in a smaller percentage contribution of the largest Dapp (D1). The 
distribution of particles with different time in mobile and bound 
states is also presented in 2D difference histograms (Fig. 6 C). 
After DNA damage induction, individual BRCA2 particles spent 
more time in a bound state and less time in the mobile state, as 
indicated by a shift of the dwell time distribution. Our combined 
results indicate that BRCA2 binding increased after DNA damage, 
a property that is not detected using FCS alone. The combined 
methods we applied here unambiguously require a bound compo-
nent for consistent analysis (Table 3). The advantages of combin-
ing methods for accurate description of nuclear protein behavior 
has been demonstrated by others investigating nuclear proteins 
p53 (Mazza et al., 2012) and the androgen receptor (Van Royen 
et al., 2014). Although we show increased binding of individual 
Figure 6. BRCA2 mobility changes after DNA damage. (A) The percentage of additionally bound BRCA2 particles was determined by SPT analysis after 
induction of DNA damage: 2 and 5 h after exposure to 10 Gy IR, after 1 h treatment with 1 mM HU, and after 24 h treatment with 1 µg/ml MMC (from at 
least six fields, nine nuclei, and 457 individual tracks for each sample, well above 1,000 tracks for most conditions). In the absence of induced DNA dam-
age, between 51 and 68% of the BRCA2 particles were bound. Three experimental replicates are shown for each treatment. (B) From all track segments, 
CDF curves were derived for the different DNA damage treatments (solid lines). Global fitting (broken lines) of the curves yielded three Dapp components, 
with D1 = 1.15 µm2/s, D2 = 0.05 µm2/s, and D3 = 0.003 µm2/s indicating mobility (D1) and transient binding interactions (D2 and D3). The percentage 
for these different mobility contributions shows that after DNA damage induced by IR, HU, and MMC, more of the observed BRCA2 is transiently bound, 
manifested as an amplitude decrease of D1 to 15%, 12%, and 13%, respectively, compared with the control condition (27%). (C) 2D difference histograms 
display mobility changes (yellow-red for increased frequency or blue for decreased frequency) after DNA damage indicating the shift to more immobile 
states compared with control (as shown in Fig. 4 A). In response to DNA damage, particles spend less time in the mobile state. Change in relative frequency 
is indicated by the colors defined on the right.
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particles compare well with the number of expected DSBs pro-
duced. 1 Gy of IR induces 20–25 DSBs in a typical cell nu-
cleus in G1 phase and double that in G2 phase, which correlates 
well with observed H2AX foci (Löbrich et al., 2010). Using 
SPT, we detected an increase of 12 bound BRCA2-GFP par-
ticles 2 h after irradiation with 10 Gy in the observation volume 
(±250 nm above and below the focal plane), which is equivalent 
to 160 additional bound BRCA2-GFP particles in the whole nu-
cleus (average). Assuming that most of the actively growing ES 
cells in the population we observe are in S phase, the number 
of additional BRCA2-GFP particles induced by 10 Gy is about 
half the value expected for H2AX foci (i.e., between 300 and 
375). This is consistent with the increased BRCA2 immobil-
ity occurring at sites of DNA damage, where BRCA2 will be 
involved in HR.
We observe that most BRCA2 travels in the nucleus as 
slowly mobile clusters (with Dapp < 2 µm2/s). We estimate that the 
clusters contain on average three BRCA2, with an equal number 
of 1, 2, and 3 plus a wide distribution of larger multimers. Though 
this association may involve additional proteins, there is growing 
evidence that human BRCA2 is multimeric. One of the original 
purification reports included EM images consistent with our 
in vivo observations, showing a variety of forms classified as one 
third monomers and two thirds dimers, though the presumed 
dimer population has a very wide size distribution that likely in-
cludes larger oligomers (Thorslund et al., 2010). Our scanning 
force microscopy analysis also reveals a variety of oligomeric 
forms for BRCA2 (Sanchez et al., 2014) purified by a different 
method (Jensen et al., 2010). Recent EM reconstructions re-
veal dimeric BRCA2 both in the absence and presence of RAD51, 
and a variety of larger forms are also evident in the raw images 
specific DNA structures, chromatin proteins, or other relatively 
stationary nuclear components. In the crowded nuclear environ-
ment, such transient interactions may be quite common, as other 
proteins also exhibit transient immobility in the 10–20 ms range 
(Grünwald et al., 2008; Speil and Kubitscheck, 2010; Van Royen 
et al., 2014). These transient interactions are likely a prominent 
influence on nuclear protein function and can now be quantita-
tively characterized. Second, BRCA2 complexes were predomi-
nantly multimeric, and estimated to consist on average of two to 
five monomers. The multimeric state of BRCA2, also recently 
reported for the purified human protein (Sanchez et al., 2014; 
Shahid et al., 2014), has important implications for its mecha-
nism of action and control in promoting HR. Third, diffusion of 
BRCA2 and RAD51 was strikingly similar, and we show that 
this was due to their association. Although these two proteins 
are known binding partners and their co-diffusion is not unex-
pected, our data suggest that most mobile nuclear RAD51 is in 
complex with BRCA2. This observation implies that BRCA2 
would be involved in all stages of RAD51 filament formation 
in vivo, and not limited to the initial filament nucleation step. 
Forth, in response to DNA damage the prevalence and duration 
of transient binding events increased, either due to an increase 
in specific interaction sites, modification of BRCA2 that favors 
interactions with immobile nuclear components, or both.
BRCA2 is needed in the cellular response to DNA dam-
age that induces DSBs or stalls replication forks (Roy et al., 2012). 
Thus, the behavior of BRCA2 in response to these types of DNA 
damage will reveal aspects of its function that contribute to DNA 
repair. We observed an increased number of bound BRCA2 par-
ticles and enhanced transient binding interactions after DNA 
damage induction (Fig. 6). The (additionally) bound BRCA2 
Table 2. Summary of the CDF diffusion analysis results for tracked BRCA2-GFP particles in live Brca2GFP/GFP cells treated with 10 Gy IR (after 2 
h), 1 µg/ml MMC (24 h), and 1 mM HU (1 h)
Damage Type D1 A1 D2 A2 D3 A3 
µm2/s % µm2/s % µm2/s % µm
Control 1 (bound) 0.59 10.7 0.037 37.9 0.002 51.4 0.009
2 (mobile) 1.21 58.8 0.098 28.0 0.003 13.2 0.016
IR 1 0.81 6.7 0.038 38.0 0.002 55.3 0.009
2 1.41 42.6 0.079 33.0 0.003 24.4 0.014
MMC 1 0.75 6.8 0.031 42.0 0.002 51.2 0.008
2 1.39 43.7 0.047 34.2 0.002 22.1 0.009
HU 1 0.94 6.9 0.029 40.3 0.002 52.8 0.008
2 1.53 32.4 0.046 37.9 0.002 29.7 0.01
Table 3. Summary of BRCA2 diffusion parameters obtained from different mobility assays in live cells.
Method D1,mob D2,mob Immobile particles B,trans
µm2/s µm2/s % ms
SPT 1.44 0.07 ∙50 ND
SPTsim 2.0 ND ND 40
FCS ND ND ND 25
Measured and simulated parameters are indicated with bold and nonbold text, respectively. D1,mob determined by SPT is lower than Dsim established by simulations, 
as expected due to reduction in dimensionality from 3D to 2D. The decay time constant B found by FCS reflects transient BRCA2 binding, as revealed by and in 
good agreement with SPT simulations. This transient binding behavior could not be directly measured by SPT because of the larger frame acquisition time of 50 ms. 
However, it produces and matches the diffusion constant D2,mob very well. The theoretical diffusion parameters established by SPT simulations yielded the apparent 
diffusion constants D1 and D2 of 1.25 (53%) and 0.06 µm2/s after analyzing the synthetically generated data.
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BRCA2 affects RAD51 in several critically important 
ways: its nuclear localization sequences are required for RAD51 
transport to the nucleus (Davies et al., 2001), its DNA bind-
ing and/or PALB2-interaction domain plays a role in delivering 
RAD51 to damage sites (Saeki et al., 2006; Siaud et al., 2011), 
and its BRC repeats control the formation and stability of the 
RAD51 filament (Rajendra and Venkitaraman, 2010; Carreira 
and Kowalczykowski, 2011). None of these functions, however, 
requires continuous interaction between RAD51 and BRCA2. For 
example, in the case of RAD51 nuclear transport, BRCA2 may 
not be the delivery vehicle, but has been suggested to facilitate 
conversion of large RAD51 oligomers into a monomeric form 
capable of diffusion through nuclear pores (Yu et al., 2003; 
Jeyasekharan et al., 2013). Other HR steps involving BRCA2 
can, in principle, similarly be accomplished by context-dependent 
rather than continuous BRCA2–RAD51 interaction. Our data in-
dicate that nuclear functions involving Rad51 will also include 
BRCA2. Continuous chaperoning by BRCA2 may be a mecha-
nism to prevent undesirable polymerization of RAD51 or inap-
propriate loading onto DNA. Importantly, the role of BRCA2 
may extend beyond the initiation of RAD51 filament formation. 
In this case, release of BRCA2 from the RAD51 filament may be 
an important point of regulatory control yet to be explored.
Materials and methods
Cell culture
Mouse ES cells were cultured in medium consisting of a 1:1 mixture of phenol- 
red free and glutamine-free DMEM (Lonza) and filtered buffalo rat liver 
(BRL)-conditioned medium, supplemented with (final concentrations given) 
7.5% fetal calf serum (Thermo Fisher Scientific), 0.1 mM nonessential amino 
acids (Lonza), 0.1 mM 2-mercaptoethanol (Sigma-Aldrich), 1,000 U/ml leu-
kemia inhibitory factor, 100 U/ml penicillin, 100 µg/ml streptomycin (both 
from the same 100× stock), and 2 mM ultraglutamine (Lonza). Cells were 
grown on gelatin-coated (Sigma-Aldrich) Petri dishes or coverslips under a 
5% CO2 atmosphere maintained at 37°C. Plasmid transfection in ES cells 
was performed using a Lipofectamine 2000 (Invitrogen) transfection proto-
col using 10 µl of reagent together with 2–10 µg of plasmid DNA prepared 
in 500 µl Optimem (Lonza) and added to 25% confluent cells grown on 
coverslips in 1 ml of ES cell medium. For mild hyperthermia treatment, cells 
were placed in an incubator, maintained at 42°C and 5% CO2, for 75 min, 
matching an effective time of 60 min at this temperature.
Generation of the Brca2GFP/GFP cell line
The Brca2-GFP targeting construct was engineered using mobile recom-
bineering reagents and protocols (Testa et al., 2004), from the clone bMQ-
178E5 from the Sanger 129/Sv BAC library (Adams et al., 2005). The 
cassette for the first recombineering step was constructed by overlap exten-
sion PCR by amplifying the EGFP with the self-cleaving viral F2A peptide 
sequence from the OCT4-EGFP targeting vector (Hockemeyer et al., 2009), 
the coding sequence for neomycin phosphotransferase resistance gene, 
and a bacterial selection cassette comprising a hygromycin resistance gene 
under a bacterial gb2 promoter, flanked by two I-SceI cleavage sites, which 
allow excision of the hygro gene after the second (retrieval) step of recom-
bineering. The cassette thus comprised EGFP-F2A-neo-ISceI-gb2-hygro-ISceI, 
and was flanked by 40-bp homology arms for inserting it in frame between 
the last codon of the Brca2 CDS and the stop codon within exon 27 of the 
mouse Brca2 gene. After the BAC modification with the cassette, a fragment 
was subcloned into a high-copy vector, a fragment of pBluescript-KS+ ampli-
fied with the primers 5-CCAGAGGACCCACGCATGGTTCCTGGCCATCT-
CAAAACAACGCAAAAGACACGCGTGCGGAACCCCTATTTGTTTAT-3  
and 5-CAGAGCAGCCCCTGCACTCCACCAATGTGTAAGGTCATTATTATT-
TATCAACGCGTTTCCAGTCGGGAAACCTGTC-3. The resulting targeting 
construct contained 6.6 plus 5.4 kb homology to the Brca2 locus flanking the 
cassette. Upon linearization with MluI and purification, 10 µg of targeting 
construct DNA was electroporated into 6 × 106 embryonic day 14 (E14) 
IB10 mouse ES cells. After 10 d of selection with 200 µg/ml G418, individual 
(Shahid et al., 2014). Our observations provide in vivo evidence 
that the recently described BRCA2 dimers, and possibly larger 
complexes, associated with RAD51 are the biologically impor-
tant forms (Shahid et al., 2014).
In FCS measurements, we did not detect putatively mono-
meric and faster diffusing BRCA2 species, thus the slowly mo-
bile and bound species fully describe BRCA2 behavior in mouse 
ES cells. Simple diffusion based on the size of a BRCA2 mono-
mer, 384 kD, would be much faster than the value measured here 
and by others (Jeyasekharan et al., 2010). For comparison, the 
460-kD TFIIH complex has a diffusion constant of 6 µm2/s when 
moving freely though the nucleus (Hoogstraten et al., 2002). 
Because diffusion constants vary with molecular weight cubed 
(simplest equation assuming spherical particles), a threefold dif-
ference (6 vs. 2 µm2/s) would be equivalent to a 27-fold differ-
ence in molecular weight, or an equivalent of 35 BRCA2. Thus, 
the apparent slow diffusion is not likely due to particle size alone 
but involves frequent, transient immobility. The component with 
Dapp of 0.45 µm2/s for BRCA2-GFP (detected by FCS) could rep-
resent chromatin-bound proteins because this is the value also re-
ported for chromatin-bound heterochromatin protein 1 (Erdel 
et al., 2011). The percentage of bound particles and the time indi-
vidual BRCA2 particles remain bound increased after DNA dam-
age induction, both of which would logically contribute to high 
local concentrations and provide a quantitative basis for describ-
ing focus formation. The challenge now is to begin building and 
testing models for how changes in the diffusion parameter we 
have defined would result in high local concentration of proteins 
at sites of DNA damage.
The diffusion behavior of RAD51 indicates that this protein 
travels in the nucleus associated with BRCA2 and that the pool of 
free diffusing RAD51 is limited. Although biochemical analysis 
often uses a large excess of RAD51 over BRCA2 (Shahid et al., 
2014), given the relative amount of these proteins in cells the 
complete association of RAD51 with BRCA2 that we observe is 
not unexpected. We estimate that BRCA2 concentration is 3–15 nM 
(see Materials and methods) and the RAD51 nuclear concentra-
tion is 100 nM (Essers et al., 2002a; Agarwal et al., 2011). Based 
on the higher value for BRCA2, most nuclear RAD51 could be 
bound to BRCA2, assuming the stoichiometry of 6:1 deter-
mined in vitro (Jensen et al., 2010). Our direct observation of 
(near) complete association between BRCA2 and mobile RAD51 
in live cell nuclei is somewhat unexpected and currently not part 
of models describing nuclear RAD51 behavior. This association 
is, however, consistent with the large volume of biochemical and 
cytological data demonstrating the tight physical and functional 
association between the two proteins (Mizuta et al., 1997; 
Sharan et al., 1997; Chen et al., 1998; Katagiri et al., 1998; Davies 
et al., 2001; Shahid et al., 2014). Additionally, BRCA2 and 
RAD51 expression levels are likely to be coregulated, and an in-
triguing example of such a homeostatic relationship has been 
described previously (Magwood et al., 2013). This further em-
phasizes the importance of maintaining native expression levels 
of proteins that work in concert for the type of in vivo analysis 
described here, where for instance overexpression of one partner 
in a complex would result in behavior quite different compared 
with the correctly partnered version.
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and cells were analyzed by FACS. The reported numbers represent five 
independent experiments.
Pull-down from Brca2GFP/GFP and wild-type cells was performed with 
GFP-TrapA beads (ChromoTek): cells grown in 145-mm culture dishes were 
washed with PBS and lysed in situ with NETT++ lysis buffer (100 mM NaCl, 
50 mM Tris HCl, pH 7.5, 5 mM EDTA, 0.5% Triton X-100, and protease in-
hibitor cocktail [Roche]). Pefabloc (Roche): 450 µl per plate was scraped off 
and centrifuged at 15,294 rcf for 15 min at 4°C; supernatant was collected 
and incubated with the washed GFP-TrapA beads for 5 h at 4°C with mixing. 
Beads were collected by centrifugation (153 rcf, 2 min, 4°C), washed three 
times with the NETT++ buffer, and boiled in Laemmli sample buffer for 5 min, 
followed by SDS-PAGE fractionation, tryptic digestion, and mass-spectrometric 
analysis. Protein identification was performed using MaxQuant software 
(Cox and Mann, 2008), the Andromeda engine (Cox et al., 2011), and by 
searching against the UniProt (mouse) database.
Plasmids and cell lines
The Rad51GFP/WT and Rad54GFP/ ES cell lines were engineered by gene 
targeting in E14 ES cells using the knock-in constructs designed to express 
the fusion protein from endogenous promoter by inserting into exon III 
(Rad51) or IV (Rad54) of the cDNA encoding the remainder of the coding 
sequence fused to EGFP followed by a PGK-neo selection cassette. This has 
been described previously (Agarwal et al., 2011; Uringa et al., 2014). Plas-
mids for the expression of the BRCA2 BRC3 repeat (amino acids 1,415–
1,483 of human BRCA2) and a control peptide (BRC3-FK, containing a 
deletion corresponding to Phe1428–Lys1434 within BRC3), both fused to a nu-
clear localization signal in pCAGGS expression vector under the CAG 
promoter, were obtained from J. Stark (Memorial Sloan-Kettering Cancer 
Center and Cornell University Graduate School of Medical Sciences, New 
York, NY) and have been described previously (Stark et al., 2002). pRFP-
C1 contains a coding sequence for monomeric mRFP1 under a CMV pro-
moter. GFP-BRCA2 (pAZ114) and BRCA2-GFP (pAZ115) expression plasmids 
were engineered by replacing the gene trap cassette in the 5-PTK-3 Pig-
gyBac vector (Cadiñanos and Bradley, 2007) with a puromycin acetyl-
transferase expression cassette driven by a PGK promoter, and BRCA2 
expression cassette consisting of a CAG promoter (1.8 kb AluI fragment 
from pCAGGS-Dre-IRES-puro; Anastassiadis et al., 2009), a human BRCA2 
coding sequence (10.3 kb NotI–XhoI fragment from the phCMV1-MBP-
BRCA2 plasmid; Jensen et al., 2010), an EGFP coding sequence PCR-
amplified from the pEGFP-N1 plasmid (Takara Bio Inc.), and bovine growth 
hormone polyadenylation signal PCR amplified from pCAGGS-Dre-IRES-
puro. Stepwise isothermal Gibson assembly was used for construction 
(Gibson et al., 2009). PCR-amplified fragments and cloning junctions were 
sequence verified. The resulting PiggyBac constructs were cotransfected 
with the PiggyBac transposase expression construct (mPB) into HeLa cells 
(1 µg each in six-well plate). Selection with 1.5 µg/ml puromycin was started 
after 1 d and maintained for 7 d. The population of puromycin-resistant 
clones was used for imaging experiments without clonal isolation. Rad54/ 
and Nbs1B/BRad54/ cells were produced by sequential targeting of 
the two wild-type alleles (Rad54/) or de novo isolation from blastocysts 
at E3.5 (Nbs1B/BRad54/; Essers et al., 1997; Brugmans et al., 2009). 
Nbs1B/+ mice used in the crosses to produce the Nbs1B/BRad54/ ES 
cells carry a hypomorphic allele of Nbs1, in which exons 4 and 5 encod-
ing the BRCT domain of NBS1 are replaced by the neo selection cassette 
(Williams et al., 2002). The Rad54 gene in Rad54/ cells is disrupted by 
insertion of the selection cassettes (neo, hygro) into exon 4, abolishing pro-
tein expression (Essers et al., 1997).
Oblique-illumination microscopy and live-cell imaging
Oblique-illumination imaging was performed on an inverted microscope 
(Eclipse Ti-E; Nikon), equipped with a Plan-Apochromat TIRF objective lens 
(100×, 1.49 NA, oil) and an EM charge-coupled device (CCD) camera 
(QuantEM; Roper Scientific). A 491-nm Calipso diode-pumped solid-state 
laser (Cobolt) was used for EGFP excitation with 5–7 mW laser power 
(100%) at the objective back focal plane. Reliable fine-tuning of the laser 
at subcritical TIRF angles (the angle of the refracted ray is 75° into the 
cell suspension with respect to the objective optical axis) for each field-
of-view was achieved using the built-in motorized illumination unit (Ti TIRF-
E; Nikon), which displaces the focusing lens parallel to the objective optical 
axis. The laser power has been adjusted for each cell line depending on 
the expression level of the GFP fusion protein to enable single-particle de-
tection and tracking while avoiding signal saturation at the EM-CCD cam-
era. A filter cube (ET-EGFP; Chroma) with an emission filter (HQ530/30M) 
was used; the excitation filter was removed. The hardware was run through 
MetaMorph 7.5 software (Molecular Devices). In combination with the 
colonies were picked, expanded, and analyzed by Southern blotting with 
an external probe; all of the colonies analyzed have undergone recombina-
tion. To produce Brca2GFP/GFP cells, one of the Brca2GFP/WT clones was further 
expanded and subjected to selection with a higher concentration of G418 
(1.5 mg/ml) for 8–10 d; several of the numerous colonies that resulted were 
expanded and analyzed by genotyping PCR and then Southern blotting. 
Conversion to homozygosity using this method was highly efficient. The 
Brca2YFP/YFP lines were engineered by following a similar protocol and using 
the pEYFP-C1 construct (Takara Bio Inc.). Three independent heterozygous 
clones were used to produce independent homozygous clones.
Western blotting was performed as described previously (Krawczyk 
et al., 2011) using primary antibodies against mouse BRCA2 (rabbit-BRCA2ab, 
27976; Abcam) and human poly(ADP-ribose) polymerase (PARP-1; C-2-10, 
raised in mouse; Enzo Life Sciences) with dilutions of 1:500 and 1:5,000, 
respectively. Protein extracts were prepared by scraping and resuspending 
confluent cells from a 10-cm dish in 100 µl of PBS. After the addition of 100 µl 
of 2× Laemmli buffer (4% SDS, 20% glycerol, and 120 mM Tris-HCl, 
pH 6.8), cells were boiled for 5 min at 95°C and subsequently sheared 
using a 1-ml syringe with a 0.5 × 16-mm needle. Protein concentration was 
determined with the Lowry assay to ensure equal loadings of 50 µg of total 
protein extract for different cell lines. SDS-PAGE was performed for 15 min 
at 50 V and 2 h at 100 V. Blotting was performed for 2 h at 300 mA and 
4°C using 2× transfer buffer (10× buffer: 250 mM Tris base and 2 M gly-
cine, pH 8.3) containing 20% (vol) methanol.
Functional assays
For colony formation survival assays, 100–1,500 cells were seeded in 
6-well culture dishes in triplicate. Cells were irradiated the next day with 
8 Gy using a 137Cs source (0.65 Gy/min). Cisplatin and PJ-34 (Sigma-
Aldrich) were added to the media 3 h after seeding the cells; media were 
replaced after 18–20 h of treatment. Dishes were stained with Coomassie 
Brilliant Blue 6 d later and photographed; macroscopically visible colonies 
were counted. Three independent experiments were performed for each 
treatment, each with three technical replicates.
To detect localization of BRCA2 with other DNA damage markers in 
IR-induced foci, Brca2GFP/GFP cells were grown on glass coverslips (diameter 
of 15 or 24 mm) precoated with 0.1% gelatin or 50 µg/ml laminin from 
mouse Engelbreth-Holm-Swarm (EHS) sarcoma (Roche), irradiated with 8 Gy, 
allowed to recover for 2 h, washed with PBS, fixed with 2% PFA for 15 min, and 
mounted in Vectashield medium with DAPI (Vector Laboratories). For RAD51 
staining before fixation, cells were pre-extracted with 0.5% Triton X-100, 
20 mM Hepes KOH, pH 7.9, 50 mM NaCl, 3 mM MgCl2, and 300 mM 
sucrose solution for 1 min, and additionally washed with PBS. Immunofluor-
escence staining was performed using primary antibodies (pAb) against 
Trp53BP1 (rabbit pAb; Novus Biologicals) or RAD51 (rabbit pAb; home-
made) and Alexa Fluor 594–conjugated secondary antibodies, all diluted 
in PBS with 0.15% glycine and 0.5% BSA. Direct BRCA2-GFP fluorescence 
and Trp53BP1 immunofluorescence staining were imaged using a laser con-
focal microscope (LSM510 Meta, 63×/1.4 NA Plan-Apochromat oil immer-
sion objective lens). RAD51 immunofluorescence data were acquired on a 
confocal microscope (SP5; Leica) equipped with a hybrid detector and a 
photomultiplier tube, with the former used for BRCA2-GFP and the latter for 
DAPI and Alexa Fluor 594 fluorophores, respectively, using a 63×/1.4 NA 
oil immersion objective lens and LSM software (Leica). Confocal scanning 
was performed at room temperature. Images were processed with ImageJ 
for intensity level adjustment and cropping. Foci were scored using an Im-
ageJ cell counter plugin (van Royen et al., 2007), the basis of which was 
the mean intensity and standard deviation of a segmented nucleus. Objects 
with an intensity larger than a defined threshold, calculated as the sum of 
the mean and three times the standard deviation, were counted as foci. The 
experiments were repeated at least twice.
For FACS analysis, cells were harvested by trypsinization, fixed with 
1% PFA in PBS for 15 min at room temperature, permeabilized with 0.2% 
Triton X-100 in PBS, washed with PBS, incubated with blocking solution (3% 
BSA and 0.2% Triton X-100 in PBS) for 20 min, incubated with anti-GFP 
monoclonal antibody (1:1,000 dilution; Roche) in blocking solution for 1 h 
at room temperature, washed three times with PBS, and then incubated with 
Alexa Fluor 488 anti–mouse secondary antibody for 30 min in darkness, 
washed three times with PBS, and incubated with 0.25 mg/ml RNase I at 
37°C for 10 min. 2 µg/ml propidium iodide was added and cells were 
analyzed by FACS. The experiment was performed twice. Efficiency of 
gene targeting by HR was determined using the Rad54-GFP gene targeting 
assay (Abraham et al., 2003), for which cells were trypsinized, collected 
by centrifugation, resuspended in 1% PFA, and incubated for 15 min; an 
equal volume of 0.2% Triton X-100 in PBS was added to the suspension 
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100-nm-sized green-fluorescent polystyrene beads (Invitrogen) obtained on a 
similar imaging setup equipped with a Nano-drive (Mad City Labs) and a 
spinning disc unit (CSU-X1; Yokogawa Electric Corporation).
The behavior of the mobile objects displaying transient (binding) inter-
actions was simulated using the Markov jump process (Wilkinson, 2011). 
In this case, the motion of the object was switched randomly between stages 
of diffusion with a coefficient DF = 2 µm2/s and DB = 0.02 µm2/s for “free 
motion” and binding, respectively. In the course of the simulation, the dura-
tion of each stage was sampled from the exponential probability distribu-
tion using the corresponding time constants F = 30 ms and B = 40 ms, 
respectively. The values of these parameters were estimated by matching 
the particle-jump histograms (of the mobile tracks) of the simulated and mea-
sured data (Fig. S4). The simulated image stacks were then subjected to the 
same ImageJ and MATLAB routines used to process the measured stream 
acquisitions. The time-step of the simulation was 1 ms, during which the 
object made a displacement of fixed size, according to the corresponding 
diffusion coefficient, in a random direction in three dimensions (van den 
Wildenberg et al., 2011). In accordance with our image acquisition set-
tings, a series of 50 displacements comprised one frame. Each simulated 
(1 ms) position was convolved with the measured Gaussian PSF profile also 
taking the z position explicitly (with respect to the focal plane) into account; 
50 time points were then summed up to obtain a corresponding image frame 
reflecting the motion of objects within the acquired 50 ms time interval. In 
total, 3D motion of 700 objects in a volume of 35.84 µm × 35.84 µm × 1.1 µm 
was simulated. Initially, the objects were randomly positioned within a cell, 
using the profile extracted from the measured data. Every 25 (50 ms) frames, 
a set of new, randomly positioned objects within the cells was added in the 
focal plane to compensate the number of objects that left the observation 
volume during the simulation. Examples of synthetic images resembled the 
measured data very well.
The measured particle jump data (histograms) were compared with 
the data obtained by simulation with D = 0.4 and 2.0 µm2/s. The optimal 
values for binding parameters B and F, were obtained by incrementally 
changing the  values in steps of 5 ms to minimize the error between two 
histograms calculated as ∑(Ei  Oi)2, with Ei  Oi being the measured and 
theoretical data points for bin i, respectively (least squares method).
The Kolmogorov-Smirnov test and the Kernel Density based global 
two-sample comparison test (Duong et al., 2012) were used to test for 
significant differences between the measured data and the two simu-
lated datasets.
FCS measurements
FCS experiments were performed on a microscope (LSM510 ConfoCor 2; 
Carl Zeiss Inc.; Weisshart et al., 2004) using a 40× C-Apochromat water 
immersion objective lens (NA 1.2), band-pass filters BP500-550 and 535-
590 for GFP and YFP, respectively, and an argon laser with a maximum 
output power of 30 mW. The laser lines at 488 and 514 nm were chosen 
for GFP and YFP excitation, respectively. Live-cell imaging was performed 
in cell growth medium under a 5% CO2 atmosphere and at 37°C using a 
stage and objective heater. Fluorescence intensity fluctuations were ac-
quired at a laser power of 1–2% from each individual cell nucleus five 
times for 20 s, after an initial bleaching period of 3 s to remove the contri-
bution of bound molecules. At least 10 different cell nuclei from each cell line 
were monitored in this way. Datasets for the Brca2GFP/GFP and Brca2YFP/YFP 
cells were replicated three times (on different days) and twice for GFP and 
YFP expression in the wild-type (IB10) cells.
Data acquisition was performed with the AIM software V3.2 using 
the module LSM-FCS (Expert Mode; Carl Zeiss). Data analysis was done 
using the FFS data processor (Scientific Software Technologies Centre). The 
autocorrelated raw data were subjected to a three-component free diffusion 
triplet-state model. The known triplet state of GFP was fixed to 4 µs (15%). 
The first decay component arises from GFP blinking and was fixed at 330 µs 
(50%; Haupts et al., 1998). YFP blinking was determined in vitro (Schwille 
et al., 2000), yielding similar blinking times of either 200 or 400 µs depend-
ing on the specific GFP mutant: T203Y or T203F, respectively. In live cells, 
however, the blinking constant changed to 100 µs, determined directly by 
(global) data fitting of YFP-expressing ES cells. The decay time and fraction 
of the remaining two components was determined by global fitting of all 
ACFs belonging to one cell condition or cell type. Using a previously estab-
lished calibration procedure with Rhodamine 6G (Weisshart et al., 2004), 
diffusion constants were derived from the fitted decay times.
BRCA2-GFP single-molecule counting in in situ fixed Brca2GFP/GFP cells
Brca2GFP/GFP cells grown on coverslips for 24 h were washed twice with 
PBS, then immersed in 4% fresh PFA, immediately mounted on a glass 
100× objective lens, the CCD camera yielded images with pixel sizes rep-
resenting 70 nm (14.28 pixel = 1 µm). Video streams typically contain-
ing 200 frames (16 bit) were collected continuously using the full camera 
chip without binning, a frame acquisition time of 50 ms, and an EM Gain 
of 950 (3×). For display, individual image frames from video stacks were 
selected, cropped, labeled with a scale bar, and converted to 8-bit, with-
out any (further) image processing, using ImageJ (Abràmoff et al., 2004). 
The lookup table is linear and covers the full range of the data. For two-
color data, images from different color channels were overlaid and the 
range of brightness was linearly adjusted.
Live-cell imaging was performed in cell growth medium under a 
5% CO2 atmosphere and at 37°C using a Tokai Hit stage heating sys-
tem. It was critical for this experiment that the cells were well attached to 
the coverslip to yield crisp raw images using oblique laser illumination. 
As ES cells have a tendency to grow in piles and to stick to each other 
rather than to the coverslip, additional optical interfaces, such as medium 
between the coverslip and the cell colony, can obscure the laser light 
path and negatively affect data quality. In total, this imaging and SPT ex-
periment (next section) was successfully performed >100 times, counting 
different cell lines and conditions. All reported data series were repeated 
at least three times (technical replicates), except for the Rad51GFP/WT and 
Rad54GFP/ cells, and the BRC3 expression experiments in the Brca2GFP/GFP 
cells, for which experimental conditions were clearly stable and the data 
reproducible.
Single-particle tracking
Single-particle tracking was performed using a custom-written plugin for Im-
ageJ (Abràmoff et al., 2004), which is available from http://www.smal 
.ws/home/software. The plugin first applied a detection algorithm based on 
a weighted least-squares Gaussian fitting of PSFs, providing intensity and 
sigma values (Thompson et al., 2002), which yielded true and false detec-
tions, the latter originating from camera noise. False detections were sepa-
rated based on an empirical approach that characterized detections based 
on the intensity-sigma statistics in non-ROIs of raw images. An exponential 
function with parameters derived from the distribution of intensity-sigma pair 
values was used as a threshold. Tracks were subsequently created for the re-
maining true detections using a nearest-neighbor linking approach with a 
cutoff value of 840 nm and visualized using the MTrackJ plugin of ImageJ 
(Meijering et al., 2012). Further, a minimum track length of four frames was 
required, and a maximum of one missing frame for connecting nearby track 
sequences was allowed. The tracks were saved to a file with six columns 
containing, respectively, the fitted x and y position, the track number, a logi-
cal value whether the track is active in the particular frame, the intensity of 
the PSF fitted spot, and the sigma of the PSF. The tracking data were im-
ported into a MATLAB script and converted into time increments in millisec-
onds and positions (x/y) in micrometers. All information from all tracks 
at one sample condition was combined. Histograms of all (squared) particle 
jumps were produced for the time increment separating two subsequent 
frames (equaling  = 50 ms) within one track. From these histograms, CDF 
curves were derived and fitted with three components i of the exponential 
decay function Ai × [r2/(4Di + 42)], with Ai denoting the amplitude (ex-
pressed as a fraction), r2 being the squared particle jumps, Di denoting the 
apparent diffusion constant, and  being the precision in particle localization 
(Schütz et al., 1997). Fitting three mobility components to the CDF curves de-
scribed the data well (R2 > 0.99). The resulting apparent diffusion coeffi-
cients, and their distribution as percentages, are summarized in Table 1 for 
the two track types (results are from Fig. 2, E and G).
Simulations of single-particle diffusion
Simulations were performed in order to compare theoretical and measured 
diffusion constants obtained by our SPT approach and the CDF diffusion analy-
sis. To create realistic synthetic image data, we simulated the diffusive behav-
ior of the objects of interest (van den Wildenberg et al., 2011). Each image 
sequence consisted of 100 frames. Each frame (size of 512 × 512 pixels, with 
lateral pixel size 70 × 70 nm) represented one of the z slices of a larger 3D 
volume where the simulated objects moved. To create realistic cell-like back-
grounds, images from the real experiments were decomposed using the un-
decimated wavelet transform (Zhang, B., J. Fadili, J.L. Starck, and J.C. 
Olivo-Marin. 2007. Proceedings of the IEEE International Conference on 
Image Processing. Abstr. 9820977) to extract the cell profiles and to estimate 
the levels of the imaging noise. This image information was added to the inten-
sity profiles of the moving objects. The appearance of the objects was mod-
eled using the Gaussian approximation of the PSF (Thomann et al., 2002; 
Zhang et al., 2007) with the following parameters: x,y = 97 nm, z = 175 
nm. These parameters were estimated using 20-nm-spaced confocal stacks of 
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postbleach (recovery) period. Data from all individual curves of one cell 
line were then averaged and plotted together. To further smooth these aver-
aged curves for qualitative comparison, a sliding time average window of 
five subsequent frames was applied. To quantify differences in final recov-
ery, and therefore long-term binding, individual raw data curves were nor-
malized with a correction factor so that the mean of the last 50 data points 
of the prebleach matches 1 and then averaged for each cell line. To assess 
statistically significant differences between different conditions, we calcu-
lated the mean and SEM for each averaged curve after recovery had been 
completed and before substantial monitor bleaching took place, i.e., within 
the time window of 8–10 s. The mean ± 2 × SEM covers 95% of the data; 
in the absence of data overlap between ranges for different conditions, this 
matches a p-value of <0.05.
Online supplemental material
Fig. S1 shows how the Brca2-GFP knock-in cell lines were generated and 
characterized using several functional assays, confirming the presence 
and wild-type behavior of the BRCA2 fusion proteins. Fig. S2 confirms the 
ability of the homozygous Brca2-GFP knock-in cell line to form IR-induced 
RAD51 foci. Fig. S3 A demonstrates how false detections were removed 
from a set of initial single-molecule detections, determined by Gaussian fit-
ting, using a novel separation approach. Fig. S3 B defines the limits of 
diffusion determination by SPT and CDF analysis of coverslip-attached, 
36-nm-sized green fluorescent beads. Fig. S4 employs single-particle sim-
ulations to refine BRCA2 diffusion parameters, i.e., transient interaction 
times, obtained by SPT and FCS. Fig. S5 shows FRAP measurements of 
protein mobility in live ES cells that provide evidence for the co-diffusion 
of BRCA2 and RAD51. Video 1 shows diffusion of single BRCA2-GFP par-
ticles imaged in a live Brca2GFP/GFP ES cell, revealing short transient inter-
actions of the mobile protein. Video 2 shows GFP-BRCA2 diffusion in a 
live HeLa cell displaying the same type of mobile behavior as BRCA2-GFP in 
ES cells. Video 3 shows BRCA2-GFP diffusion in a live HeLa cell that follows 
the same mobility pattern as GFP-BRCA2 in HeLa and BRCA2-GFP in ES 
cells. Video 4 shows RAD54-GFP fluorescence in a live Rad54GFP/ ES cell, 
revealing fast diffusing protein, seen as uniform background, and visually 
static accumulations, often referred to as spontaneous foci. Video 5 shows 
slowly diffusing RAD51-GFP particles and larger (apparently) immobile 
RAD51 accumulations imaged in a live Rad51GFP/WT ES cell. Video 6 dis-
plays live Rad51GFP/WT ES cells in which BRC3 and RFP (red) have been co-
expressed, leading to an increased RAD51-GFP (green) mobility manifested 
as uniform (green) fluorescence. Table S1 shows the mass-spectrometric 
analysis of a GFP pull-down from Brca2GFP/GFP and wild-type cells, which al-
lows determination of physical BRCA2 interaction partners. Table S2 shows 
CDF fit results of the immobilized, 36-nm-sized green fluorescent beads ( = 
50 ms) characterized by apparent pseudo-diffusion constants D as large as 
0.01 µm2/s. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.201405014/DC1. Additional data are available 
in the JCB DataViewer at http://dx.doi.org/10.1083/jcb.201405014.dv.
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slide, and imaged with oblique illumination video microscopy. These raw 
data were analyzed by a MATLAB routine. Bleaching intensity traces were 
extracted over time for objects whose pixel value was 4× the SD above the 
mean value, which was determined for the whole image, and then sub-
jected to step fitting (Kerssemakers et al., 2006). The object intensity, inte-
grated over 5 × 5-pixel windows, was corrected for the local background 
calculated from the 9 × 9 outer frame centered on the pixel of maximum in-
tensity. This yielded fluorescence intensity traces with no significant steps 
for nuclei, which appear blurred due to an unsuitable oblique illumination 
angle or which display larger fluorescent aggregates that are not single-
molecule-like. The obtained bleaching traces were categorized by calculat-
ing the SD of all intensity values from one trace and comparing the 
difference of the mean values of the first and last five intensity values. If this 
difference was lower than the SD, then the trace was used as a reference 
trace, which does not contain significant intensity steps, i.e., the mean 
value of all intensity steps obtained from these traces was determined and 
used as a lower threshold for meaningful steps. All other traces were sub-
jected to regular step fitting, whereas steps below the above-determined 
threshold value were discarded. Gaussian fitting of the distribution of all 
real intensity steps provided a cutoff value for counting the number of 
BRCA2-GFP molecules in a cluster. Steps larger than this Gaussian mean 
were counted as a single GFP molecule, steps at least twice as large as the 
mean were counted as two molecules, and steps below the Gaussian mean 
were ignored (counting method 1). Alternatively, the number of BRCA2-
GFP molecules was also counted by dividing the difference in start and 
final intensity (averaged over three frames) by the determined Gaussian 
mean (counting method 2). These two different counting methods can be 
regarded as a lower and upper estimate of the real BRCA2-GFP distribu-
tion in the clusters, respectively.
Estimation of BRCA2-GFP concentration in live Brca2GFP/GFP cells
We estimated the nuclear concentration of BRCA2-GFP based on the de-
tection of single particles in live cells. The number of detected BRCA2-GFP 
particles was multiplied by the mean number of BRCA2-GFP molecules per 
cluster, determined with the second method of counting single-molecule 
bleaching steps in fixed cells. This product was divided by the volume 
element that we effectively imaged, which was calculated as the cross- 
sectional area of the cell nucleus ( × rnucleus2) multiplied by 400 nm, assum-
ing ±200 nm imaging depth above and below the microscope focal plane, 
and an additional correction factor of 1024 × Avogadro’s constant = 
0.6022 to obtain the nuclear protein concentration directly in nanomolar. 
Based on the clusters, the range of apparent nuclear BRCA2-GFP con-
centrations, estimated from 13 individual cell nuclei, was between 0.8 
and 3 nM. This value represents a lower estimate of the nuclear BRCA2 
concentration because larger accumulations known as spontaneous foci 
are not taken into account. Using the established bleach step size of single 
BRCA2-GFP molecules, we also estimated the number of BRCA2 proteins 
in spontaneous foci to be in the range of 20–100. Background correction 
was performed in the direct vicinity using a control area of the same shape 
and size and clearly devoid of fluorescent particles. Thus, the total nuclear 
BRCA2 concentration is likely to be three- to fivefold higher than the above 
estimate, i.e., between 3 and 15 nM.
FRAP measurements
FRAP experiments were performed on a microscope (SP5; Leica) equipped 
with a HyD 3 (hybrid) detector used with a gain of 340. The microscope 
was equipped with a Plan-Apochromat 1.4 NA/63× oil immersion objec-
tive lens. Data acquisition and extraction were performed with the FRAP 
Wizard (Leica). For FRAP measurements, a 512 × 16 pixel stripe across 
the short axis of more or less ellipsoidal-shaped cell nuclei was selected, 
and ROIs were adjusted to touch the cell nuclear boundaries. During FRAP 
scanning, a zoom of 6 and scanning speed of 1,400 Hz were used. The 
488-nm line of an Argon laser was used with an acousto-optical tunable fil-
ter (AOTF) value of 8 and 100% for scanning and bleaching, respectively. 
GFP fluorescence was collected within the spectral range of 500–550 nm. 
The FRAP protocol consisted of a prebleach, bleach, and postbleach 
(recovery) period lasting 250, 10, and 5,000 frames, respectively, while the 
acquisition per frame (512 × 16 pixels) took 12 ms. Similar to the SPT and 
FCS experiments, live-cell imaging was performed in cell growth medium 
under a 5% CO2 atmosphere and at 37°C. A MATLAB script for data pro-
cessing and visualization was written. Because of the low protein expres-
sion level, data from aberrant cell nuclei were excluded. To assess diffusive 
behavior, the integrated intensity from individual ROIs, i.e., the selected 
stripes across single nuclei, was normalized between 0 and 1 for the 
lowest data point and the final part (last 50 frames), respectively, in the 
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